Back

Human neurons stimulated with IFNγ present HLA class I-restricted autoantigens to cytotoxic CD8+ T cells

Clarkson, B. D. S.; Pucci, S.; Shrestha, R. B.; Mangalaparthi, K. K.; Raja, R.; Curtis, M.; Pandey, A.; Howe, C. L.

2026-05-26 immunology
10.64898/2026.05.22.727243 bioRxiv
Show abstract

Interferon-{gamma} (IFN{gamma}) signaling is prominent in inflammatory CNS microenvironments across many neurological disorders, but the neuronal peptides presented on HLA class I under these conditions and their functional consequences for CD8+ T cells remain incompletely defined. Here we combine human iPSC-derived human neural aggregates (HNAs), HLA class I immunoprecipitation coupled to LC-MS/MS immunopeptidomics, and microfluidic co-culture assays to map IFN{gamma}-induced neuronal antigen presentation and test antigen-specific cytotoxicity. IFN{gamma} stimulation induced robust HLA class I expression in HNAs and enabled recovery of a canonical 8-12-mer class I ligandome enriched for 9-mers. Neuron-restricted expression of a synapsin-driven polyepitope cassette yielded presentation of defined neoantigen 9-mer peptides on donor HLA class I molecules and, in the presence of IFN{gamma}, elicited activation of autologous antigen-specific CD8+ T cells and consequent antigen-dependent neurite injury. Across four donors, comparative immunopeptidomics identified large IFN{gamma}-unique neural peptide repertoires distinct from matched fibroblasts and revealed a consistent enrichment of predicted high-affinity binders on HLA-B allotypes. Finally, {beta}2-microglobulin deletion ablated peptide recovery, and neuron-restricted {beta}2-microglobulin reconstitution enabled identification of neuron-derived peptides, including peptides derived from neurofilament light (NEFL) that were shared across donors and presented on multiple HLA allotypes. Together, these data provide an integrated platform for neuronal autoantigen discovery and functional validation and support a model in which IFN{gamma}-driven neuronal HLA class I presentation creates an HLA-B-weighted epitope landscape that can be recognized by autoreactive cytotoxic CD8+ T cells.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 13%
12.7%
2
Nature Immunology
71 papers in training set
Top 0.1%
10.1%
3
Immunity
58 papers in training set
Top 0.6%
8.4%
4
Science Translational Medicine
111 papers in training set
Top 0.2%
6.8%
5
Cell Reports
1338 papers in training set
Top 11%
4.3%
6
Cell Reports Medicine
140 papers in training set
Top 0.9%
4.3%
7
Science Advances
1098 papers in training set
Top 5%
3.6%
50% of probability mass above
8
Cell
370 papers in training set
Top 6%
3.6%
9
Advanced Science
249 papers in training set
Top 6%
3.3%
10
Science Immunology
81 papers in training set
Top 0.9%
2.1%
11
Brain
154 papers in training set
Top 2%
2.1%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 30%
1.9%
13
EMBO Molecular Medicine
85 papers in training set
Top 1%
1.9%
14
Nature Biotechnology
147 papers in training set
Top 4%
1.9%
15
Alzheimer's & Dementia
143 papers in training set
Top 2%
1.3%
16
Cell Systems
167 papers in training set
Top 9%
1.3%
17
Nature Nanotechnology
30 papers in training set
Top 0.8%
1.3%
18
Nature
575 papers in training set
Top 13%
1.2%
19
eLife
5422 papers in training set
Top 49%
1.2%
20
Science
429 papers in training set
Top 17%
1.2%
21
Cell Stem Cell
57 papers in training set
Top 2%
0.9%
22
Genome Medicine
154 papers in training set
Top 8%
0.8%
23
Nature Chemical Biology
104 papers in training set
Top 3%
0.8%
24
Nature Methods
336 papers in training set
Top 6%
0.7%
25
Journal of Clinical Investigation
164 papers in training set
Top 7%
0.7%
26
Nature Biomedical Engineering
42 papers in training set
Top 2%
0.7%
27
Frontiers in Immunology
586 papers in training set
Top 8%
0.7%
28
Cell Genomics
162 papers in training set
Top 7%
0.7%
29
Cell Metabolism
49 papers in training set
Top 3%
0.7%
30
Nature Medicine
117 papers in training set
Top 5%
0.7%